5AM Ventures — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for patients with autoimmune diseases.
BiotechHealthtechRadnor, US
Steven Nichtberger(Executive Officer, Director)Steven Nichtberger, MD(Founder)inDan Geffken(Executive Officer)Anup Marda(Chief Financial Officer)Mark Simon(Director)
Board seatBrian Daniels· per SEC Form D
BiotechBedford, US
Huw Nash(Executive Officer)Adrian Krainer(Executive Officer, Director, Promoter)Isabel Aznarez(Executive Officer, Director, Promoter)
Board seatArthur Tzianabos· per SEC Form D · $90M raise · filed Nov 2018
Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing.
BiotechHealthtechBrookline, US
Emmanuel Simons(Executive Officer, Director)william sewell(Founder)in
BoardEd Mathers(Director)inKush Parmar(Director)in
Board seatKush M ParmarArthur Tzianabos· per SEC Form D
Co-investorsEcoR1 CapitalNew Enterprise Associates (NEA)RA CapitalSofinnova VenturesCowen Healthcare InvestmentsFidelity Investments+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.